130 related articles for article (PubMed ID: 30714394)
1. Investigational drug labeling variability.
Duhamel A; Thibault M; Lebel D; Bussières JF; Tanguay C
Clin Trials; 2019 Apr; 16(2):204-213. PubMed ID: 30714394
[TBL] [Abstract][Full Text] [Related]
2. SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study.
Dollinger C; Schwiertz V; Sarfati L; Gourc-Berthod C; Guédat MG; Alloux C; Vantard N; Gauthier N; He S; Kiouris E; Caffin AG; Bernard D; Ranchon F; Rioufol C
Int J Qual Health Care; 2016 Jun; 28(3):311-5. PubMed ID: 26976831
[TBL] [Abstract][Full Text] [Related]
3. The variability and quality of medication container labels.
Shrank WH; Agnew-Blais J; Choudhry NK; Wolf MS; Kesselheim AS; Avorn J; Shekelle P
Arch Intern Med; 2007 Sep; 167(16):1760-5. PubMed ID: 17846395
[TBL] [Abstract][Full Text] [Related]
4. Conformity of commercial oral single solid unit dose packages in hospital pharmacy practice.
Thibault M; Prot-Labarthe S; Bussières JF; Lebel D
Int J Qual Health Care; 2008 Jun; 20(3):206-10. PubMed ID: 18337287
[TBL] [Abstract][Full Text] [Related]
5. Readability of over-the-counter medication labels.
Sansgiry SS; Cady PS; Patil S
J Am Pharm Assoc (Wash); 1997; NS37(5):522-8. PubMed ID: 9479403
[TBL] [Abstract][Full Text] [Related]
6. Using human factors methods to evaluate the labelling of injectable drugs.
Momtahan K; Burns CM; Jeon J; Hyland S; Gabriele S
Healthc Q; 2008; 11(3 Spec No.):122-8. PubMed ID: 18382173
[TBL] [Abstract][Full Text] [Related]
7. Training workload in the investigational drug service of a university hospital center.
Martel-Côté N; Choquette R; Côté-Sergerie C; Lebel D; Bussières JF; Tanguay C
Am J Health Syst Pharm; 2023 Apr; 80(8):495-502. PubMed ID: 36626282
[TBL] [Abstract][Full Text] [Related]
8. Rationalizing the use of auxiliary label for oral oncology drugs.
Ng T; Badry N; de Lemos ML
J Oncol Pharm Pract; 2017 Jul; 23(5):338-343. PubMed ID: 27208015
[TBL] [Abstract][Full Text] [Related]
9. Improving investigational drug service operations through development of an innovative computer system.
Sweet BV; Tamer HR; Siden R; McCreadie SR; McGregory ME; Benner T; Tankanow RM
Am J Health Syst Pharm; 2008 May; 65(10):969-73. PubMed ID: 18463347
[TBL] [Abstract][Full Text] [Related]
10. Investigational drug information through a hospitalwide computer system.
Iteen SA; Ceppaglia J
Am J Hosp Pharm; 1992 Nov; 49(11):2746-8. PubMed ID: 1471640
[TBL] [Abstract][Full Text] [Related]
11. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review.
Shrank W; Avorn J; Rolon C; Shekelle P
Ann Pharmacother; 2007 May; 41(5):783-801. PubMed ID: 17426075
[TBL] [Abstract][Full Text] [Related]
12. Managing oncology research protocols.
Lunik MC
Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
[TBL] [Abstract][Full Text] [Related]
13. What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France.
Fronteau C; Paré M; Benoit P; Tollec S; Hamon C; Schwiertz V; Maillard C; Cransac A; Volteau C; Huon JF; Burgeot V; Tching-Sin M; Guérin C; Flet L
PLoS One; 2019; 14(8):e0220383. PubMed ID: 31408456
[TBL] [Abstract][Full Text] [Related]
14. Investigational drug practices in Michigan hospitals.
Cohen IA; Foote ML; Kirking DM; Tankanow RM; Conlon PF
Am J Hosp Pharm; 1989 Jul; 46(7):1370-5. PubMed ID: 2757042
[TBL] [Abstract][Full Text] [Related]
15. Standardized order form for investigational drugs: effect on completeness of the prescription.
Ollivier V; Thelcide C; Simon C; Favier M
Pharm World Sci; 2004 Jun; 26(3):178-9. PubMed ID: 15230367
[TBL] [Abstract][Full Text] [Related]
16. Patients' ability to read and understand dosing instructions of their own medicines - a cross sectional study in a hospital and community pharmacy setting.
Manchanayake MGCA; Bandara GRWSK; Samaranayake NR
BMC Health Serv Res; 2018 Jun; 18(1):425. PubMed ID: 29879961
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine.
Chanda S; Sansgiry SS
J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131
[TBL] [Abstract][Full Text] [Related]
18. Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health system.
Cruz JL; Brown JN
Ther Adv Drug Saf; 2015 Jun; 6(3):103-9. PubMed ID: 26240744
[TBL] [Abstract][Full Text] [Related]
19. A systematic literature review on strategies to avoid look-alike errors of labels.
Larmené-Beld KHM; Alting EK; Taxis K
Eur J Clin Pharmacol; 2018 Aug; 74(8):985-993. PubMed ID: 29754215
[TBL] [Abstract][Full Text] [Related]
20. Dispensing investigational drugs: regulatory issues and the role of the investigational drug service.
Shehab N; Tamer H
Am J Health Syst Pharm; 2004 Sep; 61(18):1882-4. PubMed ID: 15487876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
